Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia

NCT03711227 is registered in ClinicalTrials.gov with Corewell Health South as lead sponsor.

NCT NCT03711227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03711227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
Lead sponsor
Corewell Health South
Phase
Observational
Overall status
Completed
Start date
July 17, 2018
Completion date
August 1, 2019
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia